240 related articles for article (PubMed ID: 28685346)
21. siRNA targeting stathmin inhibits invasion and enhances chemotherapy sensitivity of stem cells derived from glioma cell lines.
Song Y; Mu L; Han X; Liu X; Fu S
Acta Biochim Biophys Sin (Shanghai); 2014 Dec; 46(12):1034-40. PubMed ID: 25348735
[TBL] [Abstract][Full Text] [Related]
22. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
[TBL] [Abstract][Full Text] [Related]
23. Phosphoribosylpyrophosphate Synthetase 1 Knockdown Suppresses Tumor Formation of Glioma CD133+ Cells Through Upregulating Cell Apoptosis.
Li C; Yan Z; Cao X; Zhang X; Yang L
J Mol Neurosci; 2016 Oct; 60(2):145-56. PubMed ID: 27343059
[TBL] [Abstract][Full Text] [Related]
24. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
25. A synthetic dl-nordihydroguaiaretic acid (Nordy), inhibits angiogenesis, invasion and proliferation of glioma stem cells within a zebrafish xenotransplantation model.
Yang X; Cui W; Yu S; Xu C; Chen G; Gu A; Li T; Cui Y; Zhang X; Bian X
PLoS One; 2014; 9(1):e85759. PubMed ID: 24454929
[TBL] [Abstract][Full Text] [Related]
26. Hinokitiol Inhibits Melanogenesis via AKT/mTOR Signaling in B16F10 Mouse Melanoma Cells.
Tsao YT; Huang YF; Kuo CY; Lin YC; Chiang WC; Wang WK; Hsu CW; Lee CH
Int J Mol Sci; 2016 Feb; 17(2):248. PubMed ID: 26901194
[TBL] [Abstract][Full Text] [Related]
27. 7-Difluoromethoxyl-5,4'-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells.
Cao X; Ren K; Song Z; Li D; Quan M; Zheng Y; Cao J; Zeng W; Zou H
Oncol Rep; 2016 Aug; 36(2):1157-65. PubMed ID: 27279287
[TBL] [Abstract][Full Text] [Related]
28. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
29. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
[TBL] [Abstract][Full Text] [Related]
30. Prooxidant action of hinokitiol: hinokitiol-iron dependent generation of reactive oxygen species.
Murakami K; Ohara Y; Haneda M; Tsubouchi R; Yoshino M
Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):392-4. PubMed ID: 16364055
[TBL] [Abstract][Full Text] [Related]
31. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma.
Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C
Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821
[TBL] [Abstract][Full Text] [Related]
32. Dihydroartemisinin exhibits anti-glioma stem cell activity through inhibiting p-AKT and activating caspase-3.
Cao L; Duanmu W; Yin Y; Zhou Z; Ge H; Chen T; Tan L; Yu A; Hu R; Fei L; Feng H
Pharmazie; 2014 Oct; 69(10):752-8. PubMed ID: 25985565
[TBL] [Abstract][Full Text] [Related]
33. The role of Nrf2 in migration and invasion of human glioma cell U251.
Pan H; Wang H; Zhu L; Mao L; Qiao L; Su X
World Neurosurg; 2013; 80(3-4):363-70. PubMed ID: 22120303
[TBL] [Abstract][Full Text] [Related]
34. Effects of CD133 on the biological features and
Gao R; Sun TT
J Biol Regul Homeost Agents; 2019 Mar-Apr,; 33(2):355-364. PubMed ID: 30891998
[TBL] [Abstract][Full Text] [Related]
35. Hinokitiol increases the angiogenic potential of dental pulp cells through ERK and p38MAPK activation and hypoxia-inducible factor-1α (HIF-1α) upregulation.
Kim MK; Park HJ; Kim YD; Ryu MH; Takata T; Bae SK; Bae MK
Arch Oral Biol; 2014 Feb; 59(2):102-10. PubMed ID: 24370180
[TBL] [Abstract][Full Text] [Related]
36. Hinokitiol Inhibits Breast Cancer Cells In Vitro Stemness-Progression and Self-Renewal with Apoptosis and Autophagy Modulation via the CD44/Nanog/SOX2/Oct4 Pathway.
Chiang YF; Huang KC; Chen HY; Hamdy NM; Huang TC; Chang HY; Shieh TM; Huang YJ; Hsia SM
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612715
[TBL] [Abstract][Full Text] [Related]
37. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
38. Different Cell Responses to Hinokitiol Treatment Result in Senescence or Apoptosis in Human Osteosarcoma Cell Lines.
Yang SC; Chen HY; Chuang WL; Wang HC; Hsieh CP; Huang YF
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163553
[TBL] [Abstract][Full Text] [Related]
39. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
[TBL] [Abstract][Full Text] [Related]
40. SIRT1, a Class III Histone Deacetylase, Regulates LPS-Induced Inflammation in Human Keratinocytes and Mediates the Anti-Inflammatory Effects of Hinokitiol.
Lee JH; Moon JH; Lee YJ; Park SY
J Invest Dermatol; 2017 Jun; 137(6):1257-1266. PubMed ID: 28257794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
